Skip to content
Halia Therapeutics
-
M42’s IROS partners with Halia Therapeutics to launch first Alzheimer’s prevention trial in UAE
Alzheimer’s disease affects more than 55 million people worldwide, and that figure is projected to nearly triple by 2050.